Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4'-isomer

Inflammation Research

Volumn 47, Issue 6, 1998, Pages 270-276

  Pairet, M ^a   Van Ryn, J ^a   Schierok, H ^a   Mauz, A ^a   Trummlitz, G ^a   Engelhardt, G ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Anti inflammatory drugs (NSAIDS); COX 1; COX 2; Cyclooxygenase; Nonsteroidal

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; INDOMETACIN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN E2; THROMBOXANE B2;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; EXUDATE; FEMALE; HUMAN; HUMAN EXPERIMENT; ISOMER; KIDNEY; MALE; NONHUMAN; NORMAL HUMAN; PROSTAGLANDIN SYNTHESIS; RAT; STOMACH; STOMACH ULCER;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HUMANS; ISOENZYMES; MALE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; STOMACH ULCER; THIAZINES; THIAZOLES;

EID: 0031813031     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050329     Document Type: Article

References (31)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature (New Biol) 1971;231:232-5.
2. 2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990;265:16737-40.
3. Masferrer JL, Zweifel BS, Seibert K, Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1990;86:1375-9.
4. Masferrer JL, Seibert K, Zweifel BS, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 1992;89:3917-21.
5. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/ cyclooxygenase homologue. J Biol Chem 1991;266:12866-72.
6. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:1692-6.
7. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-8.
8. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, et al. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992;267:25934-8.
9. O'Sullivan MG, Chilton FH, Huggins EM Jr, McCall CP. Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J Biol Chem 1992;267:14547-50.
10. Habib A, Créminon C, Frobert Y, Grassi J, Pradelles P, Maclouf J. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem 1993;268:23448-54.
11. 2 mRNA in lung ribroblasts and endothelial cells in culture. Biochem Biophys Res Commun 1993;197:1465-74.
12. Szcepanski A, Moatter T, Carley WW. Gerritsen ME. Induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-1. Arthritis Rheum 1994;37:495-503.
13. 2 synthesis in rabbit synoviocytes. Arthritis Rheum 1987;30:266-73.
14. 2 and cyclooxygenase-2. Eur J Biochem 1994; 226:125-31.
15. Crofford LJ, Wilder RL, Ristimäki AP, Sano H, Remmers EF, Epps HR, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. J Clin Invest 1994;93:1095-101.
16. Knott I, Dieu M, Burton M, Houbion A, Remacle J, Raes M. Induction of cyclooxygenase by interleukin I: Comparative study between human synovial cells and chondrocytes. J Rheumatol 1994;21:462-6.
17. Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Agents Actions 1995;44:1-10.
18. Pairet M, Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: Possible physiological and therapeutic implications. Fund Clin Pharmacol 1996;10:1-15.
19. Patrignani P, Panara MR, Greco A, Fusco O, Natoli C, Iacobelli S, et al. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 1994;271:1705-10.
20. Shay H, Komarov SA, Fels SS, Meranze D, Gruenstein MA. Simple method for the uniform production of gastric ulceration in the rat. Gastroenterology 1945;5:45-61.
21. Snedecor GW, Cochran WG. Statistical Methods, 7th edition. Ames: Iowa State University Press, 1980:365-88.
22. Lazer ES, Miao CK, Cywin CL, Sorcek R, Wong HC, Meng Z, et al. Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity. J Med Chem 1997;40:980-9.
23. Reitz DB, Li JL, Norton MB, Reinhard EJ, Collins JT, Anderson GD, et al. Selective cyclooxygenase inhibitors: Novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors. J Med Chem 1994;37:3878-81.
24. Wilkerson WW, Copelan RA, Covington M, Trzaskos JM. Antiinflammatory 4,5-diarylpyrroles. 2. Activity as a function of cyclooxygenase-2 inhibition. J Med Chem 1995;38:3895-901.
25. Browner MF. X-ray crystal structure of human cyclooxygenase-2. In: Bazan N, Botting J, Vane J, editors. New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules. Dordrecht: Kluwer, 1996:71-4.
26. 2 synthase-1. Nature 1994;367: 243-9.
27. Loll PL, Garavito RM. The isoforms of cyclooxygenase: Structure and function. Curr Opin Invest Drugs 1994;3:1171-80.
28. Patrignani P, Panara MR, Santini G, Sciulli MG, Padovano R, Cipollone F, et al. Differential inhibition of cyclooxygenase activity of prostaglandin endoperoxide synthase isozymes in vitro and ex vivo in man [abstract]. Prostaglandins Leukot Essent Fatty Acids 1996;55 Suppl 1:P115.
29. Pairet M, Lidhury PS, Engelhardt G, Trummlitz G, Vane JR. Meloxicam: Cyclooxygenase selectivity, anti-inflammatory activity and gastric and renal safety [abstract]. Inflamm Res 1995;44 Suppl 3:W15/24.
30. Anderson GD, Hauser SD, NcGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996;97:2672-9.
31. Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm Res 1995; 44:423-33.